J0172 — Injection, aducanumab-avwa, 2 mg
J0172 is a HCPCS Level II code for injection, aducanumab-avwa, 2 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.
This code has been terminated
CMS terminated J0172 on December 31, 2025. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Special coverage instructions apply
There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0172
- Long descriptor
- Injection, aducanumab-avwa, 2 mg
- Short descriptor
- Inj, aducanumab-avwa, 2 mg
- Added
- January 1, 2022
- Terminated
- December 31, 2025
- BETOS
- O1E
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to J0172
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0172 is not quite right, the correct code is very often within a few positions of it.
- J0163Injection, epinephrine in sodium chloride (endo), 0.1 mg
- J0164Injection, epinephrine in sodium chloride (baxter), 0.1 mg
- J0165Injection, epinephrine, not otherwise specified, 0.1 mg
- J0166Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg
- J0167Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg
- J0168Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg
- J0169Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg
- J0171Injection, adrenalin, epinephrine, 0.1 mgterminated
- J0173Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mgterminated
- J0174Lecanemab-irmb, for intravenous injection, 1 mg
- J0175Injection, donanemab-azbt, 2 mg
- J0177Injection, aflibercept hd, 1 mg
- J0178Injection, aflibercept, 1 mg
- J0179Injection, brolucizumab-dbll, 1 mg
- J0180Injection, agalsidase beta, 1 mg
- J0184Injection, amisulpride, 1 mg
Questions about J0172
What is HCPCS code J0172?
J0172 is a HCPCS Level II code for injection, aducanumab-avwa, 2 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0172?
The CMS HCPCS file marks J0172 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.
Is J0172 still valid?
No. J0172 was terminated on December 31, 2025 and should not be used on new claims.